Novo buys rights to Chinese weight-loss pill in $2.6bn deal
Hengrui Pharma’s experimental drug could be taken just once a week
Read the full story at Financial TimesOpen in the live monitor
Hengrui Pharma’s experimental drug could be taken just once a week
Read the full story at Financial TimesOpen in the live monitor
No group discusses this yet. Start a discussion group and attach this story.